Nevro is focused on becoming a leader in neuromodulation by developing innovative, evidence based solutions. The company pioneered high frequency stimulation for the treatment of chronic pain and other neurological disorders. Nevro’s Senza® system delivers HF10™ therapy, an advanced spinal cord stimulation therapy which provides electrical pulses to the spinal cord at a rate up to 10,000 per second (10 kHz), as compared to traditional low-frequency SCS therapy, which usually deliver the electrical pulses at less than 100 pulses per second for chronic back- and leg-pain. Nevro completed an initial public offering in November 2014.
Nevro
